Promed Bioscience
Collagen products for the research, cosmetics & medical sectors
Collagen products for the research, cosmetics & medical sectors
Promed Bioscience is a biotech startup focusing on the development and supply of collagen-based biomaterials for the research, cosmetics, and medical sectors. Founded in 2017 and headquartered in Cyprus, the company has recently secured a €800.00KCorporate Round investment from Asbis in November 2022.
The company prides itself on being highly innovative and specializes in the development, manufacturing, and supply of highly purified research and medical-grade collagen. They utilize proprietary methods under carefully controlled conditions, ensuring that their collagen products meet specific customer requirements for a wide range of research, clinical, and cosmetic/skincare applications.
Overall, Promed Bioscience's dedication to innovation and their recent significant investment make them a noteworthy player in the biotech industry, poised for further growth and impact in the coming years.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Corporate Round | €800.00K | 1 | Asbis | 09 Nov 2022 |
| Seed Round | Unknown | 1 |
|
18 Jun 2020 |
No recent news or press coverage available for Promed Bioscience.
We care about your data, and we'd love to use cookies make your experience better.
